Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-19 Sale | 2026-08-20 4:09 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 404 | $49.9 | $20,160 | 246,022 (Direct) | View |
| 2026-04-17 Sale | 2026-04-21 4:55 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 20,225 | $39.99 | $808,844 | 246,426 (Direct) | View |
| 2026-04-10 Sale | 2026-04-14 4:13 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 19,865 | $35.03 | $695,823 | 266,651 (Direct) | View |
| 2026-04-08 Sale | 2026-04-09 4:30 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 360 | $34.9 | $12,564 | 286,516 (Direct) | View |
| 2026-03-25 Sale | 2026-03-26 4:41 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 10,115 | $29.99 | $303,355 | 286,876 (Direct) | View |
| 2025-12-31 Sale | 2026-01-05 4:19 pm | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 2,840 | $30.05 | $85,342 | 296,991 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-04 4:11 pm | N/A 2036-02-02 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 4:19 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 9,000 | $0 | 296,991 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 5:30 pm | N/A 2035-02-03 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 7:42 pm | N/A 2034-06-05 | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 84,904 | $0 | 84,904 (Direct) | View |
Ownership | 2024-06-06 6:59 pm | N/A N/A | Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer | 0 | $0 | 432,747 (Direct) | View |